Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05536856

Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo

Development and Clinical Evaluation of Topical 5-Fluorouracil Effervescent Powder Formulation in the Treatment of Vitiligo

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
10 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A novel approach for 5-Fluorouracil delivery based on a solid effervescent formulation is proposed . 5-Fluorouracil is water soluble (\~50mg/ml) and therefore has been used for the development of novel topical formulations including nano and microparticles intended for skin targeting. After hydration 5-Fluorouracil could form a complex, a suspension or even be formulated to generate effervescence. In effervescent technology, gas bubbles occur from the liquid after chemical reaction between alkali salts and organic acids (mainly citric or tartaric. Due to liberation in CO2 gas, the dissolution of drug in water is enhanced. The aim of this study is the development and clinical evaluation of topical 5-florouracil effervescent powder formulation in the treatment of vitiligo.

Conditions

Interventions

TypeNameDescription
DRUGa new effervescent mixture 5-florouracil formula30 patients will apply a new effervescent mixture 5-florouracil formula prepared at faculty of pharmacy (Girls) - Al-Azhar university
DRUG5-Fluorouracil plain powder30 patients will apply the 5-florouracil plain powder on the selected patch followed by 3 milliliters of water till complete dissolution of the powder

Timeline

Start date
2022-10-15
Primary completion
2025-12-30
Completion
2025-12-30
First posted
2022-09-13
Last updated
2026-01-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05536856. Inclusion in this directory is not an endorsement.